We are live on
!
Find out more
SCP
Seizert Capital Partners Portfolio holdings
AUM
$2.17B
1-Year Est. Return
11.2%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+11.2%
3 Year Est. Return
+58.29%
5 Year Est. Return
+75.11%
10 Year Est. Return
+297.99%
AUM
$4.27B
AUM Growth
+$48.5M
(+1.1%)
Cap. Flow
-$56.2M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
25.34%
Holding
228
New
16
Increased
73
Reduced
85
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$94.1M |
| 2 |
ESV
Ensco Rowan plc
ESV
|
+$85.7M |
| 3 |
Assured Guaranty
AGO
|
+$71.1M |
| 4 |
AGCO
AGCO
|
+$28.4M |
| 5 |
URS
URS CORP
URS
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$73.8M |
| 2 |
Murphy Oil
MUR
|
+$69.2M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$52.9M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$47M |
| 5 |
QEP
QEP RESOURCES, INC.
QEP
|
+$45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.7% |
| 2 | Technology | 21.56% |
| 3 | Healthcare | 13.37% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.2% |
Similar funds
SIG
ET
MMLI
ICM
MIAS
TAL
CAG
CI
Seizert Capital Partners's Q1 2014 Portfolio in Review
As of Q1 2014, Seizert Capital Partners held 228 positions worth $4.27B, up 1.1% from $4.23B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Seizert Capital Partners's Q1 2014 filing shows 16 new, 73 increased, 85 reduced and 20 closed positions. Its largest new stake was Ensco Rowan plc: 409,703 shares worth $86.5M. The largest sale was United Therapeutics, an estimated $73.8M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
- Seizert Capital Partners's largest Q1 2014 buy was Ensco Rowan plc: 409,703 shares worth $86.5M.
- Seizert Capital Partners added most to Gen Digital in Q1 2014, an estimated $94.1M increase.
- Seizert Capital Partners's biggest Q1 2014 reduction was Endo International plc, cutting an estimated $52.9M.
- Seizert Capital Partners fully exited United Therapeutics in Q1 2014, selling an estimated $73.8M.
- Seizert Capital Partners's ten largest holdings make up 25% of its $4.27B portfolio in Q1 2014.
- Seizert Capital Partners opened 16 new positions and closed 20 in Q1 2014.
- Seizert Capital Partners's portfolio value rose 1.1% quarter-over-quarter to $4.27B.
Based on Seizert Capital Partners's 13F filing for Q1 2014, filed 8 May 2014.